| |
| |
|
| Insider
Information: |
Wilkinson Peter J |
| Relationship: |
SVP, Chief Accounting ... |
| City: |
Wilmington |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,915 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$439,501 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,915 |
|
|
| Total
Value |
$439,501 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
0.0%
|
 17.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
VP of Fin./Chief Acctg... |
2008-12-31 |
828 |
|
0 |
Premium* |
|
|
Laboratory Corp of America |
LH |
SVP, Chief Accounting ... |
2024-04-29 |
2,087 |
2020-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PPDI |
Pharmaceutical Product De... |
VP of Fin./Chief Acctg. Off. |
• – – |
2007-06-30 |
4 |
A |
$29.00 |
$5,771 |
D/D |
199 |
1,286 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
VP of Fin./Chief Acctg. Off. |
• – – |
2007-08-17 |
4 |
S |
$36.73 |
$47,295 |
D/D |
(1,287) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
VP of Fin./Chief Acctg. Off. |
• – – |
2007-11-27 |
4 |
OE |
$13.00 |
$78,000 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
VP of Fin./Chief Acctg. Off. |
• – – |
2007-11-27 |
4 |
S |
$42.01 |
$252,253 |
D/D |
(6,000) |
0 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
VP of Fin./Chief Acctg. Off. |
• – – |
2007-12-31 |
4 |
A |
$34.44 |
$8,025 |
D/D |
233 |
233 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
VP of Fin./Chief Acctg. Off. |
• – – |
2008-06-30 |
4 |
A |
$36.33 |
$8,756 |
D/D |
241 |
474 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
VP of Fin./Chief Acctg. Off. |
• – – |
2008-12-31 |
4 |
A |
$26.11 |
$9,243 |
D/D |
354 |
828 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
866 |
800 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2020-02-12 |
4 |
D |
$187.51 |
$51,003 |
D/D |
(272) |
594 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2020-02-21 |
4 |
S |
$189.65 |
$56,326 |
D/D |
(297) |
297 |
0 |
% |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2021-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
150 |
576 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2021-02-04 |
4 |
D |
$223.78 |
$11,860 |
D/D |
(53) |
523 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
867 |
1,328 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2021-02-12 |
4 |
D |
$238.26 |
$62,662 |
D/D |
(263) |
1,127 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2021-02-18 |
4 |
OE |
$146.59 |
$340,251 |
D/D |
2,166 |
976 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2021-02-18 |
4 |
S |
$241.51 |
$559,589 |
D/D |
(2,317) |
343 |
0 |
% |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2021-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
50 |
1,026 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2021-08-02 |
4 |
D |
$297.61 |
$4,464 |
D/D |
(15) |
1,011 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2022-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
116 |
1,127 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2022-02-02 |
4 |
D |
$273.18 |
$11,200 |
D/D |
(41) |
1,086 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2022-02-04 |
4 |
D |
$277.48 |
$14,706 |
D/D |
(53) |
1,183 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2022-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
150 |
1,236 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2022-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
867 |
2,050 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2022-02-14 |
4 |
D |
$272.68 |
$71,169 |
D/D |
(261) |
1,789 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
SVP, Chief Accounting Officer |
• • – |
2022-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,822 |
4,611 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
